Nutriband Inc. Achieves Significant Milestone with Inclusion in Russell Indexes
Summary
Full Article
Nutriband Inc. (NASDAQ: NTRB) has reached a significant milestone by being added to the Russell Microcap, Russell Microcap Growth, Russell 3000E, and Russell 3000E Growth Indexes. This inclusion as part of the 2025 Russell indexes reconstitution underscores the market's recognition of the company's innovative AVERSA pipeline, especially AVERSA Fentanyl, which is anticipated to achieve peak annual U.S. sales ranging from $80 million to $200 million. The Russell indexes, which are maintained by FTSE Russell, are a benchmark for about $10.6 trillion in assets, highlighting the importance of this achievement for Nutriband.
Gareth Sheridan, CEO of Nutriband, pointed out that this recognition reflects the momentum behind the company's AVERSA technology. AVERSA is a groundbreaking technology designed to combat the abuse, misuse, diversion, and accidental exposure of drugs with potential for abuse, representing a significant advancement in the field of transdermal pharmaceutical products. For more information on Nutriband's accomplishments and its AVERSA technology, visit https://www.Nutriband.com.
This story is based on an article that was registered on the blockchain. The original source content used for this article is located at InvestorBrandNetwork (IBN)